| 22/06 | Cytek Biosciences, Inc. Reaffirms Earning Guidance for 2022 |  |
| 22/06 | TRANSCRIPT : Cytek Biosciences, Inc. - Analyst/Investor Day | |
| 06/06 | CYTEK BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) | |
| 06/06 | Cytek Biosciences, Inc. Elects Deborah Neff, Don Hardison as Class I Director | |
| 02/06 | CYTEK BIOSCIENCES : April 2022 Investor Presentation | |
| 01/06 | Cytek Biosciences to Host Inaugural Analyst and Investor Day | |
| 01/06 | Cytek Biosciences to Host Inaugural Analyst and Investor Day | |
| 24/05 | Cytek Biosciences Receives CE Marking for cFluor Reagents, TBNK Kit in Europe | |
| 24/05 | Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit | |
| 12/05 | INSIDER SELL : Cytek Biosciences | |
| 12/05 | CYTEK BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition an.. | |
| 11/05 | Cytek Biosciences Posts Flat Adjusted EPS, Higher Revenue for Q1; Sees 2022 Revenue at .. | |
| 11/05 | Cytek Biosciences Seeks M&A | |
| 11/05 | TRANSCRIPT : Cytek Biosciences, Inc., Q1 2022 Earnings Call, May 11, 2022 | |
| 11/05 | Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q1 EPS $0.01, vs. Street Est of $0.02 | |
| 11/05 | Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q1 Revenue $35.1M, vs. Street Est of $3.. | |
| 11/05 | Cytek Biosciences Reports First Quarter 2022 Financial Results | |
| 11/05 | Cytek Biosciences Reports First Quarter 2022 Financial Results | |
| 11/05 | Cytek Biosciences, Inc. Provides Revenue Guidance for the Full Year 2022 | |
| 11/05 | Cytek Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, .. | |
| 28/04 | Cytek Biosciences to Report First Quarter Financial Results on May 11, 2022 | |
| 28/04 | Cytek Biosciences to Report First Quarter Financial Results on May 11, 2022 | |
| 28/04 | Cytek Biosciences Appoints Todd Garland Chief Commercial Officer | |
| 28/04 | Cytek Biosciences, Inc. Appoints Todd Garland as Chief Commercial Officer | |
| 17/03 | CYTEK BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition an.. | |
| 02/03 | CYTEK BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K) | |
| 23/02 | CYTEK BIOSCIENCES : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K | |
| 23/02 | Cytek Biosciences, Inc. Provides Revenue Guidance for the Fiscal Year 2022 | |
| 23/02 | Cytek Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2.. | |
| 23/02 | Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q4 Revenue $38.9M, vs. Street Est of $3.. | |
| 23/02 | Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results | |
| 16/02 | Cytek to Participate in the 42nd Annual Cowen Health Care Conference | |
| 11/02 | Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on Febr.. | |
| 19/01 | Certain Common Stock of Cytek Biosciences, Inc. are subject to a Lock-Up Agreement Endi.. | |
| 19/01 | Certain Stock Options of Cytek Biosciences, Inc. are subject to a Lock-Up Agreement End.. | |
| 06/01 | CYTEK BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K) | |
| 06/01 | Cytek Biosciences, Inc. Appoints Vera Imper as A Class II Director | |
| 05/01 | Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity | |
| 05/01 | Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity | |
| 05/01 | Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity | |
| 2021 | CYTEK BIOSCIENCES, INC.(NASDAQGS : CTKB) added to S&P Global BMI Index | |
| 2021 | Cytek® Biosciences Marks Milestone Achievement with Shipment of 1000th Cell Analysis Sy.. | |
| 2021 | Cytek? Biosciences Marks Milestone Achievement with Shipment of 1,000th Cell Analysis S.. | |
| 2021 | CYTEK BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition an.. | |
| 2021 | Cytek Biosciences Reports Third Quarter 2021 Financial Results - Form 8-K | |
| 2021 | Earnings Flash (CTKB) CYTEK BIOSCIENCES Posts Q3 Revenue $34.4M, vs. Street Est of $33... | |
| 2021 | Earnings Flash (CTKB) CYTEK BIOSCIENCES Posts Q3 EPS $0.02, vs. Street Est of $0.02 | |
| 2021 | Cytek Biosciences Reports Third Quarter 2021 Financial Results | |
| 2021 | Cytek Biosciences Acquires Tonbo Biosciences' Cell Analysis Unit for Undisclosed Sum | |
| 2021 | Cytek Biosciences Acquires Tonbo Biosciences' Cell Analysis Business | |
| 2021 | Cytek Biosciences, Inc. Acquires Tonbo Biosciences? Cell Analysis Business | |
| 2021 | Cytek Biosciences, Inc. acquired Cell Analysis Business of Tonbo Biosciences. | |
| 2021 | Cytek Biosciences to Report Third Quarter Financial Results on November 8, 2021 | |
| 2021 | Cytek Biosciences to Report Third Quarter Financial Results on November 8, 2021 | |
| 2021 | Cytek® Biosciences Introduces New 25-Color Immunoprofiling Assay | |
| 2021 | Cytek Biosciences, Inc. Introduces New 25-Color Immunoprofiling Assay | |
| 2021 | CYTEK BIOSCIENCES, INC.(NASDAQGS : CTKB) added to S&P TMI Index | |
| 2021 | CYTEK BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Result.. | |
| 2021 | CYTEK BIOSCIENCES : Q2 Net Income Falls, Revenue Rises | |
| 2021 | CYTEK BIOSCIENCES : Earnings Flash (CTKB) CYTEK BIOSCIENCES Posts Q2 Revenue $30.4M | |
| 2021 | Cytek Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Confer.. | |
| 2021 | CYTEK BIOSCIENCES : Reports Second Quarter 2021 Financial Results | |
| 2021 | Cytek Biosciences, Inc. Announces Unaudited Consolidated Earnings Results for the Secon.. | |
| 2021 | CYTEK BIOSCIENCES, INC. : Entry into a Material Definitive Agreement (form 8-K) | |
| 2021 | CYTEK BIOSCIENCES : Says IPO Raised $237 Million After Underwriters Exercised Option to Bu.. | |
| 2021 | Cytek Biosciences Announces Full Exercise of Underwriters' Option to Purchase Additiona.. | |
| 2021 | CYTEK BIOSCIENCES : Announces Closing of Its Initial Public Offering | |
| 2021 | CYTEK BIOSCIENCES, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,.. | |
| 2021 | CYTEK BIOSCIENCES : Prices IPO at $17/Share, Expects $200 Million Gross Proceeds | |
| 2021 | Cytek Biosciences, Inc. has completed an IPO in the amount of $247.598795 million. | |
| 2021 | Cytek Biosciences, Inc. has filed an IPO in the amount of $100 million. | |
| 2017 | Cytek Biosciences, Inc. announced that it has received $12 million in funding from from.. | |
| 2016 | Cytek Biosciences, Inc. announced that it expects to receive $15 million in funding | |
| 2015 | Cytoville, Inc. announced that it has received $12.25 million in funding from Eight Roa.. | |
| 2015 | Cytoville, Inc. announced a financing transaction | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
